Literature DB >> 5811699

Methotrexate in the treatment of malignant tumours: evidence for the possible participation of host defence mechanisms.

T H Stewart, D Klassen, A F Crook.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5811699      PMCID: PMC1946105     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  The cytotoxic action of carcinolytic agents in tissue culture.

Authors:  H EAGLE; G E FOLEY
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

2.  Anti-tumour effect of activated lymphocytes.

Authors:  G J Svet-Moldavsky; Z G Kadaghidze
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

3.  Treatment of carcinoma of the head and neck with intravenous methotrexate.

Authors:  L A Leone; M M Albala; V B Rege
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

4.  Acid base and electrolyte equilibrium of arterial blood and cerebro-spinal fluid in respiratory insufficiency.

Authors:  C Saunier; M C Aug-Laxenaire; M Schibi; P Sadoul
Journal:  Respiration       Date:  1969       Impact factor: 3.580

5.  Tumour growth and anti-mitotic action. The role of spontaneous cell losses.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

6.  Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism.

Authors:  N H Ruddle; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

  6 in total
  2 in total

1.  Antigenicity of C 3 H mammary carcinoma in isogenetic hosts: preliminary studies.

Authors:  L J Bernard; M Allen; C Birchette; J Royal; M Walker
Journal:  J Natl Med Assoc       Date:  1973-03       Impact factor: 1.798

2.  The significance of lymphocytic infiltration in neuroblastoma.

Authors:  I Lauder; W Aherne
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.